Abstract
Squamous cell carcinomas of the oropharynx are among the sites within the upper aerodigestive tract most consistently treated with radiation therapy. The ability to observe directly the response to radiation therapy and to document local-regional control and failure result in their being excellent sites to investigate modifiers of radiation effects.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ang KK, Peters LJ (1992) Concomitant boost radiotherapy in the treatment of head and neck cancers. Semin Radiat Oncol 2: 31–33
Cox JD (1992) Clinical perspectives of recent developments in fractionation. Semin Radiat Oncol 2: 10–15
Cox JD, Azarnia N et al. (1990a) A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefits with ⩾69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 82-11. J Clin Oncol 8: 1543–1555
Cox JD, Pajak TF et al. (1990b) Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: preliminary report of Radiation Therapy Oncology Group Protocol 83-13. Int J Radiat Oncol Biol Phys 18: 515–521
Cox JD, Pajak TF et al. (1991) ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group Protocol 8313. Int J Radiat Oncol Biol Phys 20: 1191–1195
Cox JD, Pajak TF et al. (1992) Interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the respiratory/digestive tracts: new evidence for accelerated proliferation from RTOG Protocol 8313. Cancer 69: 2744–2748
Diener-West M, Pajak TF et al. (1991) Randomized dose-searching Phase ILe/H trials of fractionation in radiation therapy for cancer. J Natl Cancer Inst 83: 1065–1071
Fowler JF, Tanner MA et al. (1990) Further analysis of the time factor in squamous cell carcinoma of the tonsillar region. Radiother Oncol 19: 237–244
Fowler JF (1992) Brief summary of radiobiological principles in fractionated radiotherapy. Semin Radiat Oncol 2: 16–21
Horiot JC, LeFur R et al. (1992) Status of the experience of the EORTC Cooperative Group of radiotherapy with hyperfractionated and accelerated radiotherapy regimes. Semin Radiat Oncol 2: 34–37
Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Amer Stat Assoc 53: 457–481
Keane TJ, Fyles A et al. (1992) The effect of treatment duration on local control of squamous cell carcinoma of the tonsil and carcinoma of the cervix. Semin Radiat Oncol 2: 26–28
Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chem Rep 5: 163–170
Nelson DF, Scott C et al. (1993) Hyperfractionated radiation therapy and BCNU in the treatment of malignant glioma; possible advantage observed at 72 Gy bid fractions: report of RTOG 8302. Int J Radiat Oncol Biol Phys 25: 193–207
Overgaard J, Hjelm-Hansen M et al. (1988) Comparison of conventional and splitcourse radiotherapy as primary treatment in carcinoma of the larynx. Acta Oncol 27: 147–152
Pajak TF, Laramore GE. (1991) Elapsed treatment days - a critical item for radiotherapy quality control review in head and neck trials: RTOG report. Int J Radiat Oncol Biol Phys 20: 13–20
Parsons JT, Bova FJ et al. (1980) A re-evaluation of split-course technique for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 6: 1645–1652
Rojas A, Joiner MC (1989) The influence of dose per fraction on repair kinetics. Radiother Oncol 14: 329–336
Wang CC (1988) Twice-daily radiation therapy for head and neck carcinomas. Front Radiat Ther Oncol 22: 93–98
Wilson GD, McNally NJ et al. (1988) Measurement of cell kinetics in human tumors in vivo using BUdR in flow cytometry. Br J Cancer 58: 423–431
Withers HR, Taylor JMG et al. (1988) The hazards of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 27: 131–146
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Fu, K.K. et al. (1994). Carcinomas of the Oropharynx Treated with Hyperfractionated Radiation Therapy on Radiation Therapy Oncology Group Protocol 8313. In: Pape, HD., Ganzer, U., Schmitt, G. (eds) Carcinoma of the Oral Cavity and Oropharynx. Recent Results in Cancer Research, vol 134. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84971-8_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-84971-8_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-84973-2
Online ISBN: 978-3-642-84971-8
eBook Packages: Springer Book Archive